Syngenta invests in Avidex
Dr Ian Kimber is a Syngenta Principal Fellow with special interests in, and responsibilities for, immunology, allergy and inflammation. He is based at the Syngenta Central Toxicology Laboratory in Cheshire UK and has served Syngenta, and its legacy companies, for more than 20 years in a variety of scientific and management positions.
His current research interests include all aspects of allergic sensitisation and allergic disease, the biology of dendritic cells and the regulation of cutaneous immune function. Dr Kimber has published over 450 research papers, review articles and book chapters and sits on the editorial boards of immunology, pathology, dermatology and toxicology journals. In addition he serves on a variety of national and international scientific advisory boards and expert committees.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.